Teva Pharmaceutical Industries Limited (TEVA)

NYSE: TEVA · IEX Real-Time Price · USD

16.55

+0.21 (1.29%)

At close: Jul 2, 2024, 4:00 PM

16.59

+0.04 (0.24%)

After-hours: Jul 2, 2024, 7:51 PM EDT

Teva Pharmaceutical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2000
Net Income	-559	-2,446	417	-3,990	-999	Upgrade
Depreciation & Amortization	1,153	1,308	1,330	1,557	1,722	Upgrade
Share-Based Compensation	121	124	119	129	119	Upgrade
Other Operating Activities	653	2,604	-1,068	3,520	-94	Upgrade
Operating Cash Flow	1,368	1,590	798	1,216	748	Upgrade
Operating Cash Flow Growth	-13.96%	99.25%	-34.38%	62.57%	-69.42%	Upgrade
Capital Expenditures	-526	-548	-562	-578	-525	Upgrade
Acquisitions	68	61	311	67	343	Upgrade
Change in Investments	1,431	1,143	1,773	1,362	1,481	Upgrade
Other Investing Activities	-5	-	1	12	56	Upgrade
Investing Cash Flow	968	656	1,523	863	1,355	Upgrade
Debt Issued / Paid	-1,701	-1,369	-2,166	-1,880	-1,863	Upgrade
Other Financing Activities	-212	-118	-6	-5	-63	Upgrade
Financing Cash Flow	-1,913	-1,487	-2,172	-1,885	-1,926	Upgrade
Exchange Rate Effect	-30	-123	-128	8	16	Upgrade
Net Cash Flow	393	636	21	202	193	Upgrade
Free Cash Flow	842	1,042	236	638	223	Upgrade
Free Cash Flow Growth	-19.19%	341.53%	-63.01%	186.10%	-87.58%	Upgrade
Free Cash Flow Margin	5.31%	6.98%	1.49%	3.83%	1.32%	Upgrade
Free Cash Flow Per Share	0.75	0.94	0.21	0.58	0.20	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).